Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with <i>EGFR</i> MutationsSatoshi Morita, Toshihiro Nukiwa, Hajime Asahina et al.|Clinical Cancer Research|2009Cited by 189
Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: Evaluation in comparison with mesothelinKota Iwahori, Tetsuji Naka, Tadashi Osaki et al.|Lung Cancer|2008Cited by 50